Nuvation Bio, Inc. (NUVB)
3.99
-0.07
(-1.72%)
USD |
NYSE |
Nov 13, 16:00
3.98
-0.01
(-0.25%)
Pre-Market: 19:59
Nuvation Bio Gross Profit Margin (Quarterly) : 72.18% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 72.18% |
| June 30, 2026 | 68.42% |
| March 31, 2026 | 92.16% |
| December 31, 2025 | 95.66% |
| September 30, 2025 | 70.40% |
| Date | Value |
|---|---|
| June 30, 2025 | 39.33% |
| March 31, 2025 | 22.05% |
| December 31, 2024 | 22.34% |
| September 30, 2024 | -130.7% |
| June 30, 2024 | -10.87% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Pfizer Inc. | 68.17% |
| Johnson & Johnson | 68.11% |
| Merck & Co., Inc. | 71.65% |
| Bristol Myers Squibb Co. | 64.79% |
| ANI Pharmaceuticals, Inc. | 54.92% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -47.43% |
| Return on Assets | -20.41% |
| Return on Invested Capital | -23.00% |
| Profit Margin (Quarterly) | -93.21% |
| Operating Margin (Quarterly) | -93.90% |
| Return on Net Operating Assets | -228.3% |